帝尔激光(300776) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥534,634,966.09, representing an increase of 11.86% year-over-year, while the year-to-date revenue reached ¥1,440,203,195.39, up 25.05% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2024 was ¥147,363,924.29, a decrease of 10.84% year-over-year, with a year-to-date net profit of ¥383,454,765.27, which is an increase of 12.95%[3]. - The basic earnings per share for Q3 2024 was ¥0.54, down 11.48% from the previous year, while the diluted earnings per share was also ¥0.54[3]. - The total operating revenue for the third quarter of 2024 was CNY 1,440,203,195.39, an increase of 25.1% compared to CNY 1,151,733,366.24 in the same period last year[20]. - The net profit for the third quarter of 2024 was CNY 383,454,765.27, an increase of 12.93% compared to CNY 339,498,381.76 in the same period last year[21]. - The total operating profit for the quarter was CNY 432,046,646.51, an increase from CNY 375,017,555.62 in the same period last year, reflecting a growth of 15.24%[21]. - The company reported a total comprehensive income of CNY 383,803,439.34, compared to CNY 342,849,937.08 in the previous year, marking an increase of 11.88%[22]. Assets and Liabilities - The total assets at the end of Q3 2024 were ¥6,394,481,101.35, a decrease of 6.92% from the end of the previous year, while the equity attributable to shareholders increased by 8.01% to ¥3,317,996,963.08[3]. - The company's cash and cash equivalents decreased to CNY 230,746,902.65 from CNY 526,516,924.89, a decline of 56.3%[17]. - Accounts receivable increased to CNY 920,525,907.92 from CNY 738,710,410.25, representing a rise of 24.6%[17]. - Inventory decreased to CNY 1,819,779,071.36 from CNY 1,917,584,156.93, a reduction of 5.1%[17]. - Total assets decreased to CNY 6,394,481,101.35 from CNY 6,869,985,074.89, a decline of 6.9%[19]. - Total liabilities decreased to CNY 3,076,484,138.27 from CNY 3,798,039,717.31, a reduction of 19.0%[19]. - The company's equity attributable to shareholders increased to CNY 3,317,996,963.08 from CNY 3,071,945,357.58, reflecting an increase of 8.0%[19]. Cash Flow - The net cash flow from operating activities for the first nine months of 2024 was -¥84,554,539.54, a decline of 115.72% compared to the previous year, primarily due to a decrease in cash received from sales[10]. - The company's cash flow from investing activities for the first nine months of 2024 was -¥47,894,539.53, a 91.45% improvement compared to the previous year[10]. - The company incurred a total operating cash outflow of CNY 951,218,568.23, a decrease from CNY 1,067,287,232.63 in the same period last year[24]. - The investment activities resulted in a net cash outflow of CNY -47,894,539.53, compared to CNY -559,896,197.01 in the previous year, showing an improvement[24]. - The company reported a foreign exchange impact on cash and cash equivalents of CNY -2,649,135.08 during the quarter[24]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,523, with the top 10 shareholders holding a combined 56.25% of shares[11]. - Li Zhigang holds 39.94% of shares, amounting to 109,073,070 shares, with 81,804,802 shares under lock-up[11]. - Duan Xiaoting holds 7.66% of shares, totaling 20,919,394 shares, with 15,689,545 shares under lock-up[11]. - Peng Xinbo holds 4.06% of shares, equating to 11,087,365 shares, with 8,315,524 shares pledged[11]. - The company has a total of 105,959,631 shares under lock-up due to executive lock-up regulations[14]. - The top 10 shareholders include various investment funds, with the largest being the Zhuhai Fund, holding 2.98% of shares[11]. - The total number of shares held by the top 10 unrestricted shareholders is 81,804,802 shares[12]. - The company has not reported any changes in the number of restricted shares during the reporting period[14]. - The company has no shareholders participating in margin trading or lending of shares at the end of the reporting period[12]. Research and Development - Research and development expenses for the first nine months of 2024 were ¥210,655,964.52, an increase of 30.44% compared to ¥161,494,324.91 in the same period last year, driven by new product and technology development[10]. - Research and development expenses reached CNY 210,655,964.52, compared to CNY 161,494,324.91 in the previous year, indicating a growth of 30.4%[20]. - The company plans to continue focusing on R&D and market expansion strategies to drive future growth[18]. Other Financial Metrics - The total operating costs amounted to CNY 1,029,557,484.51, up from CNY 828,558,200.15, reflecting a year-over-year increase of 24.2%[20]. - The company's cash flow from financing activities was -¥155,984,016.11, a decrease of 77.79% year-over-year, primarily due to share repurchases[10]. - The company reported a significant increase in credit impairment losses, which rose by 592.57% to -¥70,255,926.01, mainly due to provisions for bad debts[10].